Karen Knudsen, American Cancer Society CEO
April 4, 2023 12:30 PM EDTUpdated April 6, 07:39 PM
Pharma
Marketing

Amer­i­can Can­cer So­ci­ety leans on phar­ma part­ners for eq­ui­ty, pa­tient care and screen­ing col­lab­o­ra­tions

Beth Snyder Bulik

Senior Editor

The Amer­i­can Can­cer So­ci­ety is both a young and an old or­ga­ni­za­tion, CEO Karen Knud­sen said in a re­cent in­ter­view with End­points News. Al­though found­ed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

From vac­cines to psy­che­delics, five drug­mak­ers on what could change un­der a Trump ad­min­is­tra­tion

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times